홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Allylamine → 2-methoxy-5-methylene-7-(trifluoroacetyl)-6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine

HRID 597904
인쇄

반응식

HRID 597904 반응식
BrC1C(CCOS(C)(=O)=O)=NC(OC)=CC=1.C(N)C=C.CCN(CC)CC.C(OC(C(F)(F)F)=O)(C(F)(F)F)=O.C([O-])(O)=O.[Na+].[CH2:46]([N:49]([CH2:56][CH2:57][C:58]1[C:63](Br)=[CH:62][CH:61]=[C:60]([O:65][CH3:66])[N:59]=1)[C:50](=[O:55])[C:51]([F:54])([F:53])[F:52])[CH:47]=[CH2:48].CC([O-])=O.[Na+]>C(#N)C.Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.CC(N(C)C)=O.CCOC(C)=O>[CH3:66][O:65][C:60]1[CH:61]=[CH:62][C:63]2[C:47](=[CH2:48])[CH2:46][N:49]([C:50](=[O:55])[C:51]([F:54])([F:53])[F:52])[CH2:56][CH2:57][C:58]=2[N:59]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

12

반응물 7

HCID 7853AllylamineHCID 8471TriethylamineHCID 9845Trifluoroacetic anhydrideHCID 516892Sodium BicarbonateHCID 517045Sodium AcetateHCID 873326163-Bromo-2-(2-methanesulfonyloxyethyl)-6-methoxypyridineHCID 87332658
n-Allyl-n-[2-(3-bromo-6-methoxypyridin-2-yl)ethyl]-2,2,2-trifluoroacetamide

생성물 1

HCID 236541062-methoxy-5-methylene-7-(trifluoroacetyl)-6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine수율 62%

시약·촉매·용매 4

HCID 178418476HCID 178418476, 화합물촉매HCID 6342Acetonitrile용매HCID 8857Ethyl Acetate용매HCID 31374Dimethylacetamide용매

실험 절차

2-Methoxy-6-methylpyridine was diluted with THF to a total volume of 20 ml. It was cooled to −78° C. and treated with nBuLi (2.5 M in hexane, 4.8 ml, 11.9 mmol). After 15 min at −78° C., HMPA (2.1 ml, 11.92 mmol) was added and the mixture was allowed to warm to 0° C. Paraformaldehyde (1.38 g, 45.85 mmol) was added and the mixture was allowed to gradually warm to ambient temperature. The reaction was quenched with NH4Cl and extracted with EtOAc. The organic layer was dried, concentrated in vacuo and purified by column chromatography to render 0.45 g (32%) of 2-(6-methoxypyridin-2-yl)ethanol. 1H-NMR (CDCl3) δ 7.49 (dd, 1H), 6.72 (d, 1H), 6.60 (d, 1H), 4.46 (br s, 1H), 3.99 (t, 2H) 3.88 (s, 3H), 2.92 (t, 2H) ppm. Br2 (1.67 ml, 32.6 mmol) was added dropwise to a mixture of 2-(6-methoxypyridin-2-yl)ethanol (5.00 g, 32.6 mmol), Na2HPO4 buffer (1.0 1) and MeOH (110 ml). After stirring for 12 h at ambient temperature, the reaction mixture was parted between EtOAc and NaHCO3. The organic phase was washed with brine, dried over Na2SO4 and concentrated in vacuo. Chromatographic purification rendered 7.00 g (93%) of 2-(3-bromo-6-methoxypyridin-2-yl)ethanol. 1H-NMR (CDCl3) δ 7.69 (d, 1H), 6.56 (d, 1H), 4.06 (t, 2H), 3.91 (s, 3H), 3.08 (t, 2H) ppm. To a solution of 2-(3-bromo-6-methoxypyridin-2-yl)ethanol (23.4 g, 0.10 mol) in DCM (468 ml) were added Et3N (13.6 g, 0.131 mol) and MsCl (12.1 g, 0.106 mol) at 0-5° C. After 30 min, the reaction mixture was quenched with sat. aq. NaHCO3 and extracted with DCM. The organic phase was successively washed with water and brine, and then dried over Na2SO4 and concentrated in vacuo to give 32.5 g (99%) of 3-bromo-2-(2-methanesulfonyloxyethyl)-6-methoxypyridine. H-NMR (CDCl3) δ 7.68 (d, 1H), 6.56 (d, 1H), 4.74 (t, 2H), 3.92 (s, 3H), 3.32 (t, 2H), 3.00 (s, 3H) ppm. A mixture of 3-bromo-2-(2-methanesulfonyloxyethyl)-6-methoxypyridine (31.3 g, 0.10 mol), allylamine (90.5 ml, 1.21 mol) in acetonitrile (156 ml) was stirred at room temperature for 2 d. The reaction mixture was concentrated in vacuo, diluted with ethyl acetate, washed with sat. aq. NaHCO3 and water, and then dried over Na2SO4. After concentration in vacuo, the crude product was dissolved in DCM (273 ml) and reacted with Et3N (25.9 ml, 0.186 mol) and TFAA (15.4 ml, 0.11 mol) for 10 min at 5-10° C. The reaction mixture was parted between EtOAc and NaHCO3 and the organic phase was washed with brine, dried over Na2SO4 and concentrated in vacuo. Chromatographic purification rendered 25.4 g (69%) of N-allyl-N-[2-(3-bromo-6-methoxypyridin-2-yl)ethyl]-2,2,2-trifluoroacetamide. 1H-NMR (CDCl3) δ 7.64 (d), 7.62 (d), 6.52 (d), 6.51 (d), 5.82 (dddd), 5.72 (dddd), 5.28-5.18 (m), 4.11 (m), 3.91 (d), 3.91 (s), 3.81 (m), 3.16 (t) ppm. A mixture of N-allyl-N-[2-(3-bromo-6-methoxypyridin-2-yl)ethyl]-2,2,2-trifluoroacetamide (5.20 g, 14.2 mmol), (PPh3)2PdCl2 (4.98 g, 7.08 mmol), NaOAc (3.49 g, 42.5 mmol) and DMA (100 ml) was stirred for 24 h at 130° C. Evaporation of solvent and chromatographic purification of the residue yielded 2.50 g (62%) of 2-methoxy-5-methylene-7-(trifluoroacetyl)-6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine. 1H-NMR (CDCl3) δ 7.51 (d, 1H), 6.61 (d, 1H), 5.39 (d, 1H), 5.30 (d, 1H), 4.43 (d, 2H), 3.94-3.87 (m, 5H), 3.20 (m, 2H) ppm. A mixture of 2-methoxy-5-methylene-7-(trifluoroacetyl)-6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine (100 mg, 349 μmol) and K2CO3 (110 mg) in MeOH (6 ml) was heated for 1 h at 60° C. The reaction mixture was concentrated in vacuo and chromatographic purification rendered 39 mg (59%) of 2-methoxy-5-methylene-6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine. 1H-NMR (CDCl3) δ 7.47 (d, 1H), 6.58 (d, 1H), 5.28 (d, 1H), 5.21 (d, 1H), 3.93 (s, 3H), 3.64 (d, 2H), 3.19 (m, 2H), 3.10 (m, 2H) ppm.

후처리

  1. concentrationThe reaction mixture was concentrated in vacuo
  2. additiondiluted with ethyl acetate
  3. washwashed with sat. aq. NaHCO3 and water
  4. dry with materialdried over Na2SO4
  5. concentrationAfter concentration in vacuo
  6. dissolutionthe crude product was dissolved in DCM (273 ml)
  7. washthe organic phase was washed with brine
  8. dry with materialdried over Na2SO4
  9. concentrationconcentrated in vacuo
  10. customChromatographic purification
  11. stirringwas stirred for 24 h at 130° C
  12. customEvaporation of solvent and chromatographic purification of the residue

출처 및 근거

ORD 기록
ord-8e1909369926426997f97ac9fb42ae0d
출처 데이터셋
uspto-grants-2011_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07897595B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트